| ADTX 0.0127 -2.31% | SOXS 4.72 -5.03% | SPCX 160.95 19.22% | DFNS 0.233 -9.20% | BITO 8.65 0.12% | RUBI 0.4676 -24.62% | TZA 4.16 -2.58% | CAST 1.55 140.68% | AAL 14.98 2.25% | INTC 124.57 6.51% | SPCE 3.91 -31.76% | SHFS 0.276 16.46% | SRXH 0.148 17.65% | NOK 14.795 5.00% | NVDA 205.19 0.16% | BYAH 1.47 40.00% | SPDN 8.81 -0.45% | TQQQ 77.52 1.99% | TSLL 13.59 3.58% | PAVS 0.208 -28.28% | CPOP 0.195 -81.43% | SMCI 30.46 -4.72% | CUPR 3.97 64.73% | VSME 1.69 52.25% | YYGH 0.119 -3.25% | SQQQ 40.04 -1.93% | RKLB 102.39 -10.79% | TSLA 406.43 1.82% | NVD 5.02 -0.40% | WOK 0.0753 -17.70% | SPY 741.75 0.54% | ASTS 82.41 -15.53% | KEEL 5.59 1.27% | ONDS 9.33 -5.09% | SPYM 87.06 0.25% | AMZN 238.55 -1.23% | XLF 53.34 1.37% | SATS 114.08 -10.97% | QQQ 721.34 0.59% | SOFI 16.58 -0.54% | PLUG 2.76 -2.47% | SOXL 234.68 4.77% | GRAB 3.3 -1.49% | DRIP 4.74 -2.47% | AMC 2.34 2.63% | IREN 59.77 5.40% | HKIT 0.5025 -10.11% | RKLZ 3.01 21.37% | RZLV 2.68 5.93% | MARA 14.08 3.45%

MetLife Inc. (NYSE: MET) Earnings Report Highlights

MetLife Inc. (NYSE: MET) is a leading global provider of insurance, annuities, and employee benefit programs. The company operates in over 40 countries and serves millions of customers worldwide. MetLife competes with other major insurers like Prudential Financial and AIG. On November 5, 2025, MetLife reported its earnings, showcasing a mixed financial performance.

MetLife achieved an earnings per share (EPS) of $2.34, surpassing the estimated $2.31. This positive EPS result reflects the company's strong earnings performance, driven by gains from its investment portfolio. The adjusted earnings per share, excluding notable items, rose by 21% to $2.37, indicating robust growth in its core operations.

Despite the EPS beat, MetLife's revenue fell short of expectations, coming in at $17.36 billion against an estimated $18.64 billion. However, the company's net income for the third quarter was $818 million. This was supported by a 15% increase in adjusted earnings, reaching $1.6 billion, largely due to higher variable investment income and volume growth.

MetLife's financial metrics provide further insight into its performance. The company has a price-to-earnings (P/E) ratio of approximately 12.31, suggesting that investors are willing to pay $12.31 for every dollar of earnings. The price-to-sales ratio is about 0.72, indicating the stock is valued at less than one times its sales, while the enterprise value to sales ratio is around 0.69. The company's financial health is underscored by its debt-to-equity ratio of approximately 0.72, showing a balanced approach to financing its assets. 

Published on: November 6, 2025